Isavuconazole is effective for the treatment of experimental cryptococcal meningitis

Nathan P. Wiederhold, Laura Kovanda, Laura K. Najvar, Rosie Bocanegra, Marcos Olivo, William R. Kirkpatrick, Thomas F. Patterson

Research output: Contribution to journalArticlepeer-review

32 Scopus citations


We evaluated the efficacy of isavuconazole against cryptococcal meningitis. Treatment with either oral isavuconazole (120 mg/kg and 240 mg/kg twice a day [BID]) or fluconazole as the positive control significantly improved survival in mice infected intracranially with either Cryptococcus neoformans USC1597 or H99 and significantly reduced brain fungal burdens for both isolates. Concentrations of isavuconazole in plasma and brain tissue also demonstrated that the greatest improvements in survival and fungal burden were associated with elevated exposures.

Original languageEnglish (US)
Pages (from-to)5600-5603
Number of pages4
JournalAntimicrobial agents and chemotherapy
Issue number9
StatePublished - Sep 1 2016

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Infectious Diseases
  • Pharmacology


Dive into the research topics of 'Isavuconazole is effective for the treatment of experimental cryptococcal meningitis'. Together they form a unique fingerprint.

Cite this